Literature DB >> 14613333

A novel in vitro dermal wound-healing model incorporating a response to mechanical wounding and repopulation of a fibrin provisional matrix.

R O'Leary1, E J Wood.   

Abstract

Previously our laboratory, and others, described an in vitro model for the study of fibroblast wound repopulation. The so-called punch-wounded, fibroblast-populated collagen lattice has been used extensively in tissue repair research. We now identify certain shortcomings with this model, which have led to its enhancement by the introduction of a provisional matrix fabricated in situ from fibrinogen and alpha-thrombin. In the previous model, fibroblasts repopulate the wound defect (WD) as a monolayer of cells and on reaching confluence, a process reminiscent of fibroplasia fills the wound space. The enhanced model, with fibrin acting as a provisional matrix, allowed fibroblasts to repopulate the WD as a three-dimensional network of cells that were morphologically different from cells migrating over the collagen substratum of the previous model. Fibroblast repopulation of the fibrin matrix was typically around double the rate of repopulation of the empty wound space. We propose this model as an enhanced, yet sufficiently reproducible, model for the study of fibroblast responses to tissue damage. It can be further enhanced by the addition of other cell types and matrix components.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14613333     DOI: 10.1290/1543-706X(2003)039<0204:ANIVDW>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  16 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

Review 2.  Fibrin and wound healing.

Authors:  R A Clark
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

3.  Integrin receptor involvement in actin cable formation in an in vitro model of events associated with wound contraction.

Authors:  P Stephens; P G Genever; E J Wood; M J Raxworthy
Journal:  Int J Biochem Cell Biol       Date:  1997-01       Impact factor: 5.085

4.  Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B.

Authors:  R M Senior; W F Skogen; G L Griffin; G D Wilner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

5.  Fabrication and reorganization of dermal equivalents suitable for skin grafting after major cutaneous injury.

Authors:  P J Rowling; M J Raxworthy; E J Wood; J N Kearney; W J Cunliffe
Journal:  Biomaterials       Date:  1990-04       Impact factor: 12.479

6.  Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro.

Authors:  E Bell; B Ivarsson; C Merrill
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

7.  Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase C-dependent pathway.

Authors:  G S Bogatkevich; E Tourkina; R M Silver; A Ludwicka-Bradley
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

8.  Haptotactic and growth stimulatory effects of fibrin(ogen) and thrombin on cultured fibroblasts.

Authors:  R Gorodetsky; A Vexler; J An; X Mou; G Marx
Journal:  J Lab Clin Med       Date:  1998-03

9.  Thrombin stimulates fibroblast chemotaxis and replication.

Authors:  K E Dawes; A J Gray; G J Laurent
Journal:  Eur J Cell Biol       Date:  1993-06       Impact factor: 4.492

10.  Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix.

Authors:  D Greiling; R A Clark
Journal:  J Cell Sci       Date:  1997-04       Impact factor: 5.285

View more
  1 in total

1.  Mechanical boundary conditions bias fibroblast invasion in a collagen-fibrin wound model.

Authors:  Andrew D Rouillard; Jeffrey W Holmes
Journal:  Biophys J       Date:  2014-02-18       Impact factor: 4.033

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.